SU‐E‐T‐638: Treatment Margins Expansion for CyberKnife Treatment Plans
Purpose: The CyberKnife uses an online prediction model to track moving targets. The system works well if patients can breathe regularly. However, some patients cannot maintain a regular breathing pattern, which means a larger PTV margin is necessary for these patients to ensure sufficient CTV dose...
Saved in:
| Published in | Medical Physics Vol. 39; no. 6; pp. 3852 - 3853 |
|---|---|
| Main Authors | , , , , , , , , , |
| Format | Conference Proceeding Journal Article |
| Language | English |
| Published |
United States
American Association of Physicists in Medicine
01.06.2012
|
| Subjects | |
| Online Access | Get full text |
| ISSN | 0094-2405 2473-4209 2473-4209 |
| DOI | 10.1118/1.4735727 |
Cover
| Abstract | Purpose: The CyberKnife uses an online prediction model to track moving targets. The system works well if patients can breathe regularly. However, some patients cannot maintain a regular breathing pattern, which means a larger PTV margin is necessary for these patients to ensure sufficient CTV dose coverage. However, it is very difficult to predict a patient's breathing pattern in advance. The purpose of this study is to investigate a quick and easy way to adapt the treatment plan if extra margins are needed. Methods: Multiple algorithms have been developed to calculate the adjustment. Generally, if a larger target region requires coverage by the prescription dose, the size of the beams will be larger and they should move in a peripheral direction for a certain distance to avoid hot spots. Dose is recalculated and renormalized consistently after the adjustment. If the dose distribution of the new plan covers the new PTV with acceptable conformality and coverage, the plan will be used for treatment. Otherwise, more iterations of the adjustment are performed. Dose calculations are limited to a small region surrounding the target to reduce calculation time. Results: 5 clinical cases (3 lungs, 1 liver and 1 adrenal) have been tested in this study. The dose margin can be extended up to 10 mm without changing dose distributions around the target region dramatically. The average PTV coverage is 98.7% compared to 99.1% in the original plans and the average CI is 1.22, which is slightly less than the 1.24 in the original plans. Conclusions: Treatment margins can be sufficiently expanded resulting in satisfactory plan quality for patients with breathing irregularities. |
|---|---|
| AbstractList | Purpose: The CyberKnife uses an online prediction model to track moving targets. The system works well if patients can breathe regularly. However, some patients cannot maintain a regular breathing pattern, which means a larger PTV margin is necessary for these patients to ensure sufficient CTV dose coverage. However, it is very difficult to predict a patient's breathing pattern in advance. The purpose of this study is to investigate a quick and easy way to adapt the treatment plan if extra margins are needed. Methods: Multiple algorithms have been developed to calculate the adjustment. Generally, if a larger target region requires coverage by the prescription dose, the size of the beams will be larger and they should move in a peripheral direction for a certain distance to avoid hot spots. Dose is recalculated and renormalized consistently after the adjustment. If the dose distribution of the new plan covers the new PTV with acceptable conformality and coverage, the plan will be used for treatment. Otherwise, more iterations of the adjustment are performed. Dose calculations are limited to a small region surrounding the target to reduce calculation time. Results: 5 clinical cases (3 lungs, 1 liver and 1 adrenal) have been tested in this study. The dose margin can be extended up to 10 mm without changing dose distributions around the target region dramatically. The average PTV coverage is 98.7% compared to 99.1% in the original plans and the average CI is 1.22, which is slightly less than the 1.24 in the original plans. Conclusions: Treatment margins can be sufficiently expanded resulting in satisfactory plan quality for patients with breathing irregularities. The CyberKnife uses an online prediction model to track moving targets. The system works well if patients can breathe regularly. However, some patients cannot maintain a regular breathing pattern, which means a larger PTV margin is necessary for these patients to ensure sufficient CTV dose coverage. However, it is very difficult to predict a patient's breathing pattern in advance. The purpose of this study is to investigate a quick and easy way to adapt the treatment plan if extra margins are needed.PURPOSEThe CyberKnife uses an online prediction model to track moving targets. The system works well if patients can breathe regularly. However, some patients cannot maintain a regular breathing pattern, which means a larger PTV margin is necessary for these patients to ensure sufficient CTV dose coverage. However, it is very difficult to predict a patient's breathing pattern in advance. The purpose of this study is to investigate a quick and easy way to adapt the treatment plan if extra margins are needed.Multiple algorithms have been developed to calculate the adjustment. Generally, if a larger target region requires coverage by the prescription dose, the size of the beams will be larger and they should move in a peripheral direction for a certain distance to avoid hot spots. Dose is recalculated and renormalized consistently after the adjustment. If the dose distribution of the new plan covers the new PTV with acceptable conformality and coverage, the plan will be used for treatment. Otherwise, more iterations of the adjustment are performed. Dose calculations are limited to a small region surrounding the target to reduce calculation time.METHODSMultiple algorithms have been developed to calculate the adjustment. Generally, if a larger target region requires coverage by the prescription dose, the size of the beams will be larger and they should move in a peripheral direction for a certain distance to avoid hot spots. Dose is recalculated and renormalized consistently after the adjustment. If the dose distribution of the new plan covers the new PTV with acceptable conformality and coverage, the plan will be used for treatment. Otherwise, more iterations of the adjustment are performed. Dose calculations are limited to a small region surrounding the target to reduce calculation time.5 clinical cases (3 lungs, 1 liver and 1 adrenal) have been tested in this study. The dose margin can be extended up to 10 mm without changing dose distributions around the target region dramatically. The average PTV coverage is 98.7% compared to 99.1% in the original plans and the average CI is 1.22, which is slightly less than the 1.24 in the original plans.RESULTS5 clinical cases (3 lungs, 1 liver and 1 adrenal) have been tested in this study. The dose margin can be extended up to 10 mm without changing dose distributions around the target region dramatically. The average PTV coverage is 98.7% compared to 99.1% in the original plans and the average CI is 1.22, which is slightly less than the 1.24 in the original plans.Treatment margins can be sufficiently expanded resulting in satisfactory plan quality for patients with breathing irregularities.CONCLUSIONSTreatment margins can be sufficiently expanded resulting in satisfactory plan quality for patients with breathing irregularities. The CyberKnife uses an online prediction model to track moving targets. The system works well if patients can breathe regularly. However, some patients cannot maintain a regular breathing pattern, which means a larger PTV margin is necessary for these patients to ensure sufficient CTV dose coverage. However, it is very difficult to predict a patient's breathing pattern in advance. The purpose of this study is to investigate a quick and easy way to adapt the treatment plan if extra margins are needed. Multiple algorithms have been developed to calculate the adjustment. Generally, if a larger target region requires coverage by the prescription dose, the size of the beams will be larger and they should move in a peripheral direction for a certain distance to avoid hot spots. Dose is recalculated and renormalized consistently after the adjustment. If the dose distribution of the new plan covers the new PTV with acceptable conformality and coverage, the plan will be used for treatment. Otherwise, more iterations of the adjustment are performed. Dose calculations are limited to a small region surrounding the target to reduce calculation time. 5 clinical cases (3 lungs, 1 liver and 1 adrenal) have been tested in this study. The dose margin can be extended up to 10 mm without changing dose distributions around the target region dramatically. The average PTV coverage is 98.7% compared to 99.1% in the original plans and the average CI is 1.22, which is slightly less than the 1.24 in the original plans. Treatment margins can be sufficiently expanded resulting in satisfactory plan quality for patients with breathing irregularities. |
| Author | Tam, T Chen, L Ma, C Wang, L Price, R Jin, L Chen, X Koren, S Hayes, S Fan, J |
| Author_xml | – sequence: 1 givenname: J surname: Fan fullname: Fan, J organization: Fox Chase Cancer Center, Philadelphia, PA – sequence: 2 givenname: X surname: Chen fullname: Chen, X organization: Fox Chase Cancer Center, Philadelphia, PA – sequence: 3 givenname: S surname: Koren fullname: Koren, S organization: Fox Chase Cancer Center, Philadelphia, PA – sequence: 4 givenname: L surname: Jin fullname: Jin, L organization: Fox Chase Cancer Center, Philadelphia, PA – sequence: 5 givenname: L surname: Chen fullname: Chen, L organization: Fox Chase Cancer Center, Philadelphia, PA – sequence: 6 givenname: R surname: Price fullname: Price, R organization: Fox Chase Cancer Center, Philadelphia, PA – sequence: 7 givenname: L surname: Wang fullname: Wang, L organization: Fox Chase Cancer Center, Philadelphia, PA – sequence: 8 givenname: S surname: Hayes fullname: Hayes, S organization: Fox Chase Cancer Center, Philadelphia, PA – sequence: 9 givenname: T surname: Tam fullname: Tam, T organization: Fox Chase Cancer Center, Philadelphia, PA – sequence: 10 givenname: C surname: Ma fullname: Ma, C organization: Fox Chase Cancer Center, Philadelphia, PA |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/28517548$$D View this record in MEDLINE/PubMed |
| BookMark | eNp90MtKw0AUBuBBKvaiC19AslQhOmcumYw7KfWCLRZs18MkmUgkTepMinbnI_iMPokjieJGF4dzFh8_h3-IelVdGYQOAZ8BQHwOZ0xQLojYQQPiz5ARLHtogLFkIWGY99HQuSeMcUQ53kN9EnMQnMUDNH1Yfry9T_ws_EQ0vggW1uhmZaommGn7WFQumLyudeWKugry2gbjbWLsXVXk5hedl17so91cl84cdHuElleTxfgmnN5f344vp2FKKBVhrA3LWcQlSRg2mkotRES1THNNAFPI0oyABi0h4UISk_AoykjGctA6lTGjI3Tc5q5t_bwxrlGrwqWm9D-YeuMUSIyBcEKlp0cd3SQrk6m1LVbabtV3Ax6ctCC1tXPW5D8EsPpqV4Hq2vU2bO1LUZrt31DN5p0_bb1Li0Y3vsB_wj8BY4-G4Q |
| CODEN | MPHYA6 |
| ContentType | Conference Proceeding Journal Article |
| Copyright | American Association of Physicists in Medicine 2012 American Association of Physicists in Medicine 2012 American Association of Physicists in Medicine. |
| Copyright_xml | – notice: American Association of Physicists in Medicine – notice: 2012 American Association of Physicists in Medicine – notice: 2012 American Association of Physicists in Medicine. |
| DBID | AAYXX CITATION NPM 7X8 |
| DOI | 10.1118/1.4735727 |
| DatabaseName | CrossRef PubMed MEDLINE - Academic |
| DatabaseTitle | CrossRef PubMed MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic PubMed |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Physics |
| EISSN | 2473-4209 |
| EndPage | 3853 |
| ExternalDocumentID | 28517548 10_1118_1_4735727 MP5727 |
| Genre | miscellaneous Journal Article |
| GroupedDBID | --- --Z -DZ .GJ 0R~ 1OB 1OC 29M 2WC 33P 36B 3O- 4.4 476 53G 5GY 5RE 5VS AAHHS AANLZ AAQQT AASGY AAXRX AAZKR ABCUV ABEFU ABFTF ABJNI ABLJU ABQWH ABTAH ABXGK ACAHQ ACBEA ACCFJ ACCZN ACGFO ACGFS ACGOF ACPOU ACSMX ACXBN ACXQS ADBBV ADBTR ADKYN ADOZA ADXAS ADZMN AEEZP AEGXH AEIGN AENEX AEQDE AEUYR AFBPY AFFPM AHBTC AIACR AIAGR AIURR AIWBW AJBDE ALMA_UNASSIGNED_HOLDINGS ALUQN AMYDB ASPBG BFHJK C45 CS3 DCZOG DRFUL DRMAN DRSTM DU5 EBD EBS EJD EMB EMOBN F5P G8K HDBZQ HGLYW I-F KBYEO LATKE LEEKS LOXES LUTES LYRES MEWTI O9- OVD P2P P2W PALCI PHY RJQFR RNS ROL SAMSI SUPJJ SV3 TEORI TN5 TWZ USG WOHZO WXSBR XJT ZGI ZVN ZXP ZY4 ZZTAW AAHQN AAIPD AAMNL AAYCA ABDPE AFWVQ AITYG ALVPJ AAMMB AAYXX ADMLS AEFGJ AEYWJ AGHNM AGXDD AGYGG AIDQK AIDYY AIQQE CITATION LH4 NPM 7X8 |
| ID | FETCH-LOGICAL-c2337-8ae4f46592b40ea39a7763a9cfa21031dcd21a1a91b5792eb566d2d4f1aac9843 |
| ISSN | 0094-2405 2473-4209 |
| IngestDate | Thu Sep 04 16:38:37 EDT 2025 Thu Apr 03 08:17:03 EDT 2025 Wed Oct 01 03:18:13 EDT 2025 Wed Jan 22 17:06:45 EST 2025 Fri Jun 21 00:28:31 EDT 2024 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 6 |
| Keywords | Lungs Liver |
| Language | English |
| License | http://onlinelibrary.wiley.com/termsAndConditions http://doi.wiley.com/10.1002/tdm_license_1 2012 American Association of Physicists in Medicine. |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-c2337-8ae4f46592b40ea39a7763a9cfa21031dcd21a1a91b5792eb566d2d4f1aac9843 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| PMID | 28517548 |
| PQID | 1900125239 |
| PQPubID | 23479 |
| PageCount | 2 |
| ParticipantIDs | pubmed_primary_28517548 crossref_primary_10_1118_1_4735727 scitation_primary_10_1118_1_4735727 proquest_miscellaneous_1900125239 wiley_primary_10_1118_1_4735727_MP5727 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | June 2012 |
| PublicationDateYYYYMMDD | 2012-06-01 |
| PublicationDate_xml | – month: 06 year: 2012 text: June 2012 |
| PublicationDecade | 2010 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States |
| PublicationTitle | Medical Physics |
| PublicationTitleAlternate | Med Phys |
| PublicationYear | 2012 |
| Publisher | American Association of Physicists in Medicine |
| Publisher_xml | – name: American Association of Physicists in Medicine |
| SSID | ssj0006350 |
| Score | 2.0151126 |
| Snippet | Purpose: The CyberKnife uses an online prediction model to track moving targets. The system works well if patients can breathe regularly. However, some... The CyberKnife uses an online prediction model to track moving targets. The system works well if patients can breathe regularly. However, some patients cannot... |
| SourceID | proquest pubmed crossref wiley scitation |
| SourceType | Aggregation Database Index Database Publisher |
| StartPage | 3852 |
| SubjectTerms | Liver Lungs |
| Title | SU‐E‐T‐638: Treatment Margins Expansion for CyberKnife Treatment Plans |
| URI | http://dx.doi.org/10.1118/1.4735727 https://onlinelibrary.wiley.com/doi/abs/10.1118%2F1.4735727 https://www.ncbi.nlm.nih.gov/pubmed/28517548 https://www.proquest.com/docview/1900125239 |
| Volume | 39 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NbhMxEB5BKmg5QSkl_Gn5Ebct9djLrrmhEFSVBlVqIuW2sr221EtSpakEnPoIPCNPwnjX62zUFgGH3TiO14n8OePxzDcegDcOteLWYYrayVTYDFNlFKa8csJyx01e2ztGX98fTMThNJu2ucpDdMlS75kf18aV_A-qVEe4-ijZf0A2dkoVVCZ86U4I0_0qxtcuNa2fpSZytrz1EOMxiUSGYSyNY4n-EbVpPRLNfcpbz5cZfiMBcd4yEAfftV188QSYTlOf6WgVN9KYUKO9eRDiPaZRls8Xdt3KenjaCXgIJgfP3WipUa0YlcK7ZRp3tK3rUOQ8Fbgvu6K1OacoTKGunORFc25tWHPpLb9BnvsYBbbnEySTpnUbNpCTjOrBxsdPo6OTuOaS2tQEG4UfFs6QosffxYfXNY8r24l7sElKR8N_WN-p1KrG-D7srIIwk-OI-QO4ZWfbcHcUuBDbcCdg_hCOTia_Ln8O6RrTRcB-SCJWSYA1ibAmBGuygrXTtIZ1Byafh-PBQRqyZKQGOScVQ1nhhPeOa7FvFZcqpzVDSeMU-hwelamQKaYk01ku0WpS4CushGNKGVkI_gh6s_nMPoYEjWKmEIg5fa5FoRyrpGKcWVFkNsc-vGpHsDxrDkMpm01kUbIyDHMfXrZjW5Ko8v4nNbPzi_OSdE-aTBly2YfdZtBjN0iaf0675z68jij86Tve1vjc3KIcHfuXJ3_V3VPYWk3zZ9BbLi7sc9I1l_pFmGi_AWxTdO8 |
| linkProvider | EBSCOhost |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=proceeding&rft.title=Medical+Physics&rft.atitle=SU%E2%80%90E%E2%80%90T%E2%80%90638%3A+Treatment+Margins+Expansion+for+CyberKnife+Treatment+Plans&rft.au=Fan%2C+J&rft.au=Chen%2C+X&rft.au=Koren%2C+S&rft.au=Jin%2C+L&rft.date=2012-06-01&rft.issn=0094-2405&rft.eissn=2473-4209&rft.volume=39&rft.issue=6&rft.spage=3852&rft.epage=3853&rft_id=info:doi/10.1118%2F1.4735727 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0094-2405&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0094-2405&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0094-2405&client=summon |